CME Group Inc (CME)
Official siteFINANCIAL SERVICES • FINANCIAL DATA & STOCK EXCHANGES • NASDAQ
Market Cap: $113.81B
Last updated: Nov 17, 2026 at 11:05 AM ET
CME Group Inc (CME) Earnings: Report Dates and Results
CME Group (CME) is expected to report earnings on Feb 2, 2027. In the quarter ended Sep 30, 2026, CME Group reported EPS of $3.02, above the $2.98 estimate. It beat the EPS estimate in 6 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
CME has an expected report date of Feb 2, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 10.5% above the $2.77 reported for the quarter ended Dec 31, 2025.
CME Earnings Call
The latest CME earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 40 quarters below that had an estimate, CME beat 34, missed 5 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $1.74B, up 13.0% from $1.54B a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $3.02 | $2.98 | $2.90 - $3.07 | +1.34% | Beat | +12.7% | 14 | 7 up, 2 down | Oct 21, 2026 | $1.74B |
| Jun 30, 2026 | $2.99 | $2.91 | $2.84 - $2.94 | +2.75% | Beat | +1.0% | 12 | 2 up, 1 down | Jul 22, 2026 | $1.71B |
| Mar 31, 2026 | $3.36 | $3.37 | $3.29 - $3.48 | -0.30% | Miss | +20.0% | 13 | 11 up, 1 down | Apr 22, 2026 | $1.88B |
| Dec 31, 2025 | $2.77 | $2.74 | $2.70 - $2.78 | +1.09% | Beat | +9.9% | 12 | 6 up, 6 down | Feb 4, 2026 | $1.65B |
| Sep 30, 2025 | $2.68 | $2.63 | $2.56 - $2.67 | +1.90% | Beat | 0.0% | 14 | 4 up, 10 down | Oct 22, 2025 | $1.54B |
| Jun 30, 2025 | $2.96 | $2.92 | $2.85 - $3.00 | +1.37% | Beat | +15.6% | 15 | 3 up, 9 down | Jul 23, 2025 | $1.69B |
| Mar 31, 2025 | $2.80 | $2.81 | $2.78 - $2.86 | -0.36% | Miss | +12.0% | 15 | 12 up, 1 down | Apr 23, 2025 | $1.64B |
| Dec 31, 2024 | $2.52 | $2.45 | $2.40 - $2.48 | +3.05% | Beat | +6.3% | 15 | 4 up, 10 down | Feb 12, 2025 | $1.53B |
| Sep 30, 2024 | $2.68 | $2.65 | $2.61 - $2.73 | +1.13% | Beat | +19.1% | 15 | 11 up, 1 down | Oct 23, 2024 | $1.58B |
| Jun 30, 2024 | $2.56 | $2.53 | $2.50 - $2.57 | +1.19% | Beat | +11.3% | 13 | 6 up, 1 down | Jul 24, 2024 | $1.53B |
| Mar 31, 2024 | $2.50 | $2.45 | $2.39 - $2.50 | +2.04% | Beat | +3.3% | 14 | 5 up, 1 down | Apr 24, 2024 | $1.49B |
| Dec 31, 2023 | $2.37 | $2.28 | $2.23 - $2.33 | +3.95% | Beat | +23.4% | 14 | 2 up, 0 down | Feb 14, 2024 | $1.44B |
| Sep 30, 2023 | $2.25 | $2.22 | $2.18 - $2.27 | +1.35% | Beat | +13.6% | 14 | 9 up, 0 down | Oct 25, 2023 | $1.34B |
| Jun 30, 2023 | $2.30 | $2.19 | $2.15 - $2.25 | +5.02% | Beat | +16.8% | 15 | 13 up, 0 down | Jul 26, 2023 | $1.36B |
| Mar 31, 2023 | $2.42 | $2.38 | $2.29 - $2.47 | +1.68% | Beat | +14.7% | 14 | 12 up, 0 down | Apr 26, 2023 | $1.44B |
| Dec 31, 2022 | $1.92 | $1.88 | $1.82 - $1.94 | +2.13% | Beat | +15.7% | 15 | 2 up, 0 down | Feb 8, 2023 | $1.21B |
| Sep 30, 2022 | $1.98 | $1.94 | $1.89 - $1.99 | +2.06% | Beat | +23.7% | 15 | 9 up, 0 down | Oct 26, 2022 | $1.23B |
| Jun 30, 2022 | $1.97 | $1.93 | $1.89 - $1.98 | +2.07% | Beat | +20.1% | 13 | 10 up, 0 down | Jul 27, 2022 | $1.24B |
| Mar 31, 2022 | $2.11 | $2.00 | $1.93 - $2.08 | +5.50% | Beat | +17.9% | 16 | 10 up, 0 down | Apr 27, 2022 | $1.35B |
| Dec 31, 2021 | $1.66 | $1.64 | $1.59 - $1.70 | +1.22% | Beat | +19.4% | 15 | N/A | Feb 9, 2022 | $1.15B |
| Sep 30, 2021 | $1.60 | $1.55 | $1.52 - $1.64 | +3.23% | Beat | +15.9% | 14 | N/A | Oct 27, 2021 | $1.11B |
| Jun 30, 2021 | $1.64 | $1.61 | $1.56 - $1.72 | +1.86% | Beat | +0.6% | 17 | N/A | Jul 28, 2021 | $1.18B |
| Mar 31, 2021 | $1.79 | $1.76 | $1.54 - $1.80 | +1.70% | Beat | -23.2% | 18 | N/A | Apr 28, 2021 | $1.25B |
| Dec 31, 2020 | $1.39 | $1.36 | $1.32 - $1.52 | +2.21% | Beat | -8.6% | 18 | N/A | Feb 10, 2021 | $1.10B |
| Sep 30, 2020 | $1.38 | $1.44 | $1.32 - $1.48 | -4.17% | Miss | -27.4% | 18 | N/A | Oct 28, 2020 | $1.08B |
| Jun 30, 2020 | $1.63 | $1.64 | $1.56 - $1.66 | -0.61% | Miss | -7.4% | 17 | N/A | Jul 29, 2020 | $1.18B |
| Mar 31, 2020 | $2.33 | $2.21 | $2.20 - $2.28 | +5.43% | Beat | +43.8% | 17 | N/A | Apr 29, 2020 | $1.52B |
| Dec 31, 2019 | $1.52 | $1.55 | $1.51 - $1.62 | -1.94% | Miss | -14.1% | 17 | N/A | Feb 12, 2020 | $1.14B |
| Sep 30, 2019 | $1.90 | $1.75 | $1.67 - $1.79 | +8.57% | Beat | +31.0% | 16 | N/A | Oct 30, 2019 | $1.28B |
| Jun 30, 2019 | $1.76 | $1.76 | $1.72 - $1.79 | 0.00% | In line | +1.1% | 15 | N/A | Jul 31, 2019 | $1.27B |
| Mar 31, 2019 | $1.62 | $1.60 | $1.52 - $1.67 | +1.25% | Beat | -12.9% | 15 | N/A | May 1, 2019 | $1.18B |
| Dec 31, 2018 | $1.77 | $1.72 | $1.46 - $1.77 | +2.91% | Beat | +58.0% | 16 | N/A | Feb 14, 2019 | $1.24B |
| Sep 30, 2018 | $1.45 | $1.43 | $1.41 - $1.44 | +1.40% | Beat | +21.8% | 10 | N/A | Oct 25, 2018 | $904.20M |
| Jun 30, 2018 | $1.74 | $1.72 | $1.69 - $1.75 | +1.16% | Beat | +41.5% | 9 | N/A | Jul 26, 2018 | $1.06B |
| Mar 31, 2018 | $1.86 | $1.85 | $1.59 - $1.87 | +0.54% | Beat | +52.5% | 10 | N/A | Apr 26, 2018 | $1.11B |
| Dec 31, 2017 | $1.12 | $1.10 | $1.07 - $1.11 | +1.82% | Beat | -1.8% | 13 | N/A | Feb 1, 2018 | $900.00M |
| Sep 30, 2017 | $1.19 | $1.16 | $1.13 - $1.17 | +2.59% | Beat | +13.3% | 14 | N/A | Oct 26, 2017 | $890.80M |
| Jun 30, 2017 | $1.23 | $1.21 | $1.20 - $1.21 | +1.65% | Beat | +12.8% | 12 | N/A | Aug 1, 2017 | $924.60M |
| Mar 31, 2017 | $1.22 | $1.20 | N/A | +1.67% | Beat | +6.1% | N/A | N/A | Apr 27, 2017 | $929.30M |
| Dec 31, 2016 | $1.14 | $1.10 | N/A | +3.64% | Beat | +23.9% | N/A | N/A | Feb 2, 2017 | $912.90M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $11.21, up 9.3% from the year before. It was $4.43 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $11.21 | +9.3% |
| Dec 31, 2024 | $10.26 | +9.9% |
| Dec 31, 2023 | $9.34 | +17.0% |
| Dec 31, 2022 | $7.98 | +19.3% |
| Dec 31, 2021 | $6.69 | N/A |
| Dec 31, 2020 | $6.73 | -1.0% |
| Dec 31, 2019 | $6.80 | N/A |
| Dec 31, 2018 | $6.82 | +43.3% |
| Dec 31, 2017 | $4.76 | +7.4% |
| Dec 31, 2016 | $4.43 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 9,300 words across 22 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 9,347 | 22 | |
| 2026Q2 | Jun 30, 2026 | 9,979 | 21 | |
| 2026Q1 | Mar 31, 2026 | 10,659 | 21 | |
| 2025Q4 | Dec 31, 2025 | 6,961 | 17 | |
| 2025Q3 | Sep 30, 2025 | 8,243 | 22 | |
| 2025Q2 | Jun 30, 2025 | 7,736 | 24 | |
| 2025Q1 | Mar 31, 2025 | 9,848 | 23 | |
| 2024Q4 | Dec 31, 2024 | 9,041 | 20 |
2026Q3 Earnings Call
Opening remarks
Adam Minick Vice President, Investor Relations Good morning, and I hope you're all doing well today. Earlier this morning, we released our earnings commentary, which provides extensive details on the third quarter 2026, which we will be discussing on this call. I'll start with the safe harbor language, and then I'll turn it over to Terry. Statements made on this call and in the other reference documents on our websites that are not historical facts are forward-looking statements. These statements are not guarantees of future performance. They involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied in any statement. Detailed information about factors that may affect our performance can be found in the filings with the SEC, which are on our website. Lastly, in the earnings release, you will see a reconciliation between GAAP and non-GAAP measures following the financial statements. With that, I'll turn the call over to our Chairman and CEO, Terry Duffy.
Terry Duffy Chairman and CEO Thanks, Adam, and thank you all for joining us this morning. I'll make a few comments about our exceptional third quarter performance before turning it over to Lynne to provide an overview of our financial results. In addition to Lynne, we have other members of our management team present to answer questions after the prepared remarks. Against a backdrop of shifting central bank policies, geopolitical uncertainty, and persistent market volatility, global participants continue to turn to CME Group in record numbers. The third quarter average daily volume of 29.4 million contracts was the highest third-quarter average daily volume in CME Group's history and increased 16% compared to the same period last year. This strong growth was broad-based as we achieved double-digit year-over-year volume growth in all six asset classes. Our financial and commodity products volume each grew by 16%. Beyond the strong volume growth, the underlying health of the business is perhaps best reflected in the strength of our open interest and the significant capital efficiencies we provide to our customers. Quarter-end open interest reached 128 million contracts, and today it is over 133 million, the highest open interest at the end of September in our history. As I said, this open interest continues to grow in October. We also set a record for the number of large open interest holders in both our interest rates and foreign exchange complexes in September. Additionally, we delivered record levels of capital efficiency in the third quarter, saving our customers an average of over $100 billion a day in margin savings. This was a record third quarter for our international business as well, where average daily volume reached 9 million contracts, up 22% versus last year.
Frequently Asked Questions About CME
When is CME Group's next earnings date?
CME Group's next earnings report is expected for Feb 2, 2027.
Did CME beat earnings estimates last quarter?
Yes. CME Group reported EPS of $3.02 for the quarter ended Sep 30, 2026, above the $2.98 estimate, a 1.34% surprise.
What EPS do analysts expect from CME next quarter?
The consensus EPS estimate for CME Group for the quarter ending Dec 31, 2026 is $3.06 from 16 analysts, with estimates from $2.86 to $3.44.
How often does CME beat earnings estimates?
CME Group beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +1.36%.
CME pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors